PortfoliosLab logoPortfoliosLab logo
ELVA vs. NUTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ELVA vs. NUTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Electrovaya Inc. Common Shares (ELVA) and Nutex Health Inc (NUTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ELVA achieves a 20.25% return, which is significantly higher than NUTX's -12.28% return.


ELVA

1D
-3.16%
1M
-0.52%
YTD
20.25%
6M
43.50%
1Y
181.07%
3Y*
37.56%
5Y*
9.63%
10Y*
2.89%

NUTX

1D
-1.78%
1M
14.33%
YTD
-12.28%
6M
-21.90%
1Y
18.09%
3Y*
31.22%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELVA vs. NUTX - Yearly Performance Comparison


2026 (YTD)2025202420232022
ELVA
Electrovaya Inc. Common Shares
20.25%218.55%-18.95%-17.30%-1.33%
NUTX
Nutex Health Inc
-12.28%419.47%17.37%-90.53%-81.82%

Correlation

The correlation between ELVA and NUTX is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Apr 4, 2022

0.12

Fundamentals

EPS

ELVA:

$0.11

NUTX:

$19.08

PE Ratio

ELVA:

87.86

NUTX:

7.57

PEG Ratio

ELVA:

1.04

NUTX:

0.06

PS Ratio

ELVA:

6.21

NUTX:

0.83

Total Revenue (TTM)

ELVA:

$70.74M

NUTX:

$879.95M

Gross Profit (TTM)

ELVA:

$22.01M

NUTX:

$417.67M

EBITDA (TTM)

ELVA:

$6.86M

NUTX:

$275.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELVA vs. NUTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELVA
ELVA Risk / Return Rank: 8787
Overall Rank
ELVA Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
ELVA Sortino Ratio Rank: 8686
Sortino Ratio Rank
ELVA Omega Ratio Rank: 8484
Omega Ratio Rank
ELVA Calmar Ratio Rank: 8888
Calmar Ratio Rank
ELVA Martin Ratio Rank: 8787
Martin Ratio Rank

NUTX
NUTX Risk / Return Rank: 5151
Overall Rank
NUTX Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
NUTX Sortino Ratio Rank: 5454
Sortino Ratio Rank
NUTX Omega Ratio Rank: 5353
Omega Ratio Rank
NUTX Calmar Ratio Rank: 5050
Calmar Ratio Rank
NUTX Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELVA vs. NUTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Electrovaya Inc. Common Shares (ELVA) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ELVANUTXDifference
Sharpe ratioReturn per unit of total volatility

+1.84

Sortino ratioReturn per unit of downside risk

+1.72

Omega ratioGain probability vs. loss probability

1.32

1.11

+0.21

Calmar ratioReturn relative to maximum drawdown

3.80

0.29

+3.51

Martin ratioReturn relative to average drawdown

9.01

0.50

+8.51

ELVA vs. NUTX - Sharpe Ratio Comparison

The current ELVA Sharpe Ratio is 2.00, which is higher than the NUTX Sharpe Ratio of 0.17. The chart below compares the historical Sharpe Ratios of ELVA and NUTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ELVA vs. NUTX - Drawdown Comparison

The maximum ELVA drawdown since its inception was -96.90%, roughly equal to the maximum NUTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for ELVA and NUTX.


Loading charts...

Drawdown Indicators


ELVANUTXDifference

Max Drawdown

Largest peak-to-trough decline

-96.90%

-99.93%

+3.03%

Max Drawdown (1Y)

Largest decline over 1 year

-44.42%

-54.32%

+9.90%

Max Drawdown (3Y)

Largest decline over 3 years

-64.19%

-94.36%

+30.17%

Max Drawdown (5Y)

Largest decline over 5 years

-66.78%

Max Drawdown (10Y)

Largest decline over 10 years

-96.90%

Current Drawdown

Current decline from peak

-41.01%

-97.59%

+56.58%

Average Drawdown

Average peak-to-trough decline

-73.62%

-97.18%

+23.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.71%

30.94%

-12.23%

Volatility

ELVA vs. NUTX - Volatility Comparison

Electrovaya Inc. Common Shares (ELVA) has a higher volatility of 27.27% compared to Nutex Health Inc (NUTX) at 17.20%. This indicates that ELVA's price experiences larger fluctuations and is considered to be riskier than NUTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ELVANUTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.27%

17.20%

+10.07%

Volatility (6M)

Calculated over the trailing 6-month period

63.77%

63.60%

+0.17%

Volatility (1Y)

Calculated over the trailing 1-year period

84.18%

94.82%

-10.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

69.12%

191.90%

-122.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.10%

191.90%

-105.80%

Dividends

ELVA vs. NUTX - Dividend Comparison

Neither ELVA nor NUTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ELVA vs. NUTX - Financials Comparison

This section allows you to compare key financial metrics between Electrovaya Inc. Common Shares and Nutex Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M20222023202420252026
17.80M
216.49M
(ELVA) Total Revenue
(NUTX) Total Revenue
Values in USD except per share items

ELVA vs. NUTX - Profitability Comparison

The chart below illustrates the profitability comparison between Electrovaya Inc. Common Shares and Nutex Health Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%20222023202420252026
31.0%
42.4%
Portfolio components
ELVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Electrovaya Inc. Common Shares reported a gross profit of 5.51M and revenue of 17.80M. Therefore, the gross margin over that period was 31.0%.

NUTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a gross profit of 91.73M and revenue of 216.49M. Therefore, the gross margin over that period was 42.4%.

ELVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Electrovaya Inc. Common Shares reported an operating income of 1.52M and revenue of 17.80M, resulting in an operating margin of 8.5%.

NUTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported an operating income of 81.27M and revenue of 216.49M, resulting in an operating margin of 37.5%.

ELVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Electrovaya Inc. Common Shares reported a net income of 1.00M and revenue of 17.80M, resulting in a net margin of 5.6%.

NUTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a net income of 46.81M and revenue of 216.49M, resulting in a net margin of 21.6%.


Frequently Asked Questions


ELVA and NUTX have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ELVA has higher volatility (27.27%) compared to NUTX (17.20%). In terms of maximum drawdown, ELVA dropped -96.90% vs NUTX's -99.93%.

ELVA currently has the higher Sharpe Ratio (2.00 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ELVA and NUTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer